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Abstract
A simple competition model, which couples Gompertz and logistic growth mechanisms,
is presented in order to study the growth pattern of two different types of tumour cells
growing together. It is shown that the model prediction is in fairly good agreement with
the experimental finding.
1. INTRODUCTION
Cancer research has been one of the major areas of medical research for a long time.
However, still there are many aspects of tumour growth which are not well understood
by medical scientists. In a recent experimental study [9], human tumours were grown as
xenografts in nude mice and the differences in the rates of growth at contralateral sites
were examined. It was found that the tumour pieces implanted into the dorsal left flanks
of the mice grew into significantly larger tumours than the ones implanted into the dorsal
right flanks. This was true for the tumour types such as colon carcinoma Colo-205 and
gastric carcinoma MKN 45. A somewhat similar finding was noted for mouse tumours
too. It was not clear why there should be such anatomical differences in growth rates.
But it was hypothesized that it could be due to the effect of morphogenetic gradients as
in the case of control differentiation during ontogeny.
In some other experimental investigations controversial results have been reported in
regard to the effect of interferons on human myelogeneous cell line (HL-60) established
from the peripheral blood of a person with acute promyelocytic leukemia. Certain studies
$[2,4]$ find that these cells are insensitive to human alpha and beta interferons. However,
there are other studies [10] which show that alpha and beta interferons are effective in the
inhibition of HL-60 and do not concur with data in [4]. A convincing explanation either
to justify both sets of results or to repudiate one of them is still not available.
Further, most of the research has concentrated on homogeneous tumour growth. It
is known that [1] stage A2 prostatic cancer is composed of a heterogeneous group of tu-
mours. But there are not many pathologic studies which investigate this heterogeneity.
The question is, can one come up with mathematical models for tumour growth which
could be useful for the experimentalists? Since tumour growth experiments can produce
lots of quantitative data, it should be possible to construct such models. In this paper,
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we look at the problem of heterogeneity in tumour growth and construct a mathematical
model. This model is shown to satisfy some of the experimental findings available. We
believe that experimentalists could find this simple model very useful.
2. MATHEMATICAL MODEL
One of the growth curves that has been widely used [3, 7, 11] in characterising tumour
growth is the S-shaped Gompertzian growth curve. This curve is given by the equation,
$N(t)=\kappa\exp[-\exp(a-bt)]$ (1)
where $N(t)$ is the total number of tumour cells at time $t$ , $\kappa$ , the carrying capacity and
$a,$
$b$ are appropriate constants. The expression in (1) can be thought of as the solution of




where $\alpha$ is a positive constant. If the growth curve is a simple exponential growth curve
$\gamma(t)$ will be just a positive constant in (2).
It can be argued that there is no particular reason to expect the Gompertz curve to
show any wider range of fitting power to a given data set than any other S-shaped curve
with three constants. For example, the logistic curve which can be written as,
$N(t)=\kappa/[1+\exp(a-bt)]$ (4)
is also S-shaped and has three constants $\kappa$ (having the same meaning as $\kappa$ in (1)), $a$ and
$b$ . This curve can also be employed to fit any given data. But it should be noted that
there is a subtle difference between the Gompertz and the logistic curves. Although, both
curves have points of inflection when $t=a/b$, the ordinate that corresponds to Gompertz
is $\kappa/e$ while that corresponds to logistic is $\kappa/2$ . This means, that in the cases of Gompertz
and logistic the point of inflection occurs when approximately 37% and 50% respectively,
of the total growth has been realized. So, it is really up to the experimentalist to decide
on the best fitting growth curve for his or her experimental data by determining where
the point of inflection should be.
In order to understand the experiments reported in [9] (as mentioned in the previous
section), where larger tumours in the left flank were seen than in the right flank, we tried
to fit the data obtained for gastric carcinoma MKN 45 by different types of growth curves.
It is seen (figures 1 and 2) that Gompertz type curves are the best fitting curves for these
data (number of tumour cells are assumed to be proportional to tumour volume). Further,
the only difference between the Gompertz expression in the left flank and that of the right
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is the constant $\kappa$ . The values of the constants $a$ and $b$ in both cases do not change. This
implies that the left flank has a larger carrying capacity than the right. So, one could
argue that the anatomical differences in growth rates of any particular type of tumour
cells are essentially due to differing carrying capacities of different regions and nothing
else.
Now, we will focus on the problem of two types of tumour cells growing together. In
this case, the two cell populations must compete for vital nutrients, growth factors, etc. A
study consisting of Ehrlich ascites cells (of different types) proliferating in the peritoneum
of mice was carried out in [5]. The types of cells examined were diploid and tetraploid
cells. It was found [5, 6, 8] that no matter what the initial distribution of cells were, at the
steady state, always, 96% of the total number of cells were diploid and 4% were tetraploid.
Can a mathematical model predict this finding? In order to answer this we construct the
following competition model:
$\frac{dN_{1}}{dt}=rN_{1}(\ln\kappa-\ln N_{1})-\alpha N_{1}N_{2}$ (5)
$\frac{dN_{2}}{dt}=sN_{2}(L-N_{2})-\beta N_{1}N_{2}$ (6)
where $N_{1}$ and $N_{2}$ are the number of diploid cells and tetraploid cells respectively at any
given time $t$ . The terms $\alpha N_{1}N_{2}$ and $\beta N_{1}N_{2}$ relate to the competition between the cell
populations with $\alpha$ and $\beta$ being positive constants. As can be noted from equations (5)
and (6), we have taken the growth of diploid cells to be Gompertz growth and of tetraploid
cells to be logistic growth. This is simply because the growth data of diploid cells growing
on their own and of tetraploid cells growing on their own given in [5] were found best fitted
by Gompertz and logistic curves, respectively.
In order to analyse the model, let us consider the phase plane diagram for the equations
(5) and (6) (figure 3). It is clear that there are four steady states with $(0,0),$ $(\kappa, 0)$ and
$(0, L)$ being the trivial ones. The only non-trivial steady state is given by the point of
intersection of the curves,
$N_{2}= \frac{r}{\alpha}\ln(\kappa/N_{1})$ and $N_{2}=L- \frac{\beta}{s}N_{1}$
and it can be easily checked that this steady state is asymptotically stable. So, this could
be the steady state which relates to 96% to 4%.
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$Growt1_{1}$ curve of MKN45 tumor xenograft in left flank.
Growth curve of MKN45 tumor xenograft in right flank.
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Fig. 3
Phase plane diagram for the Competition model.
In [5], the growth data for diploid and tetraploid cells growing together are also given.
Using this data set along with the data set when these cell populations are growing on
their own, we are able to estimate the constants $\kappa,$ $L,$ $r,$ $s,$ $\alpha$ and $\beta$ . It should be pointed
out that for this estimation procedure only data up to 8 days are used. In the experi-
ments the steady state is reached after day 20. This means that our estimation is done
at the initial transient phase of the growth process. Is it possible for our model to predict
what happens after day 20 using these (up to 8 day) estimates? We obtain the answer to
this by numerically solving the coupled ordinary differential equations (5) and (6) using
the estimated values for the constants. The result is presented in figure 4 and it is obvious
that the steady state is reached after day 20. But, what percentage are the diploid cells
of the total cell population at steady state? We find this to be around 91%. Compare it
to the value (96%) obtained in experiments. Clearly, the model’s prediction is very good,
if one makes allowances for the experimental errors, estimation errors and so on.
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Fig. 4
Numerically simulated growth curves for diploid and tetraploid cells.
3. CONCLUDING REMARKS
In this short paper, a simple competition model is developed to describe the growth
of two different types of tumour cells growing together. We demonstrated that the model
can predict the experimental finding fairly well. It should be pointed out that this model
can be easily expanded or modified if one needs to have more than two different cell
types. For example, if the tetraploid cells springing from diploid cells through endomitotic
differentiation are to be considered in a study, one can simply assume them to be a third
type of cells. Then, all we need, to modify the mathematical model are an extra growth
equation (in differential form) for this third type of cell and a loss term in the growth
equation for diploids. Therefore, we feel that the model presented here could be a very
valuable quantitative tool to the experimentalists.
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